FdaApplication
ANDA 220642
Identifiers
- fda_app_no: ANDA220642
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMACEUTICALS |
| application_type | ANDA |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DAPAGLIFLOZIN AND METFORMIN | DAPAGLIFLOZIN, METFORMIN | 500MG | TABLET, EXTENDED RELEASE |
| DAPAGLIFLOZIN AND METFORMIN | DAPAGLIFLOZIN, METFORMIN | 2.5MG | TABLET, EXTENDED RELEASE |
| DAPAGLIFLOZIN AND METFORMIN | DAPAGLIFLOZIN, METFORMIN | 5MG | TABLET, EXTENDED RELEASE |
| DAPAGLIFLOZIN AND METFORMIN | DAPAGLIFLOZIN, METFORMIN | 10MG | TABLET, EXTENDED RELEASE |
4 products